(Q38064381)

English

Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.

scientific article published on December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

0 references

1 reference

Europe PubMed Central

Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

quality of life

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

interstitial lung disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Irene Higginson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Jonathan Koffman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

author name string

Joy R Ross

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Athol U Wells

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Amit Suresh Patel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Julia Riley

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Janet L Peacock

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

language of work or name

0 references

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

867-879

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23204065%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Specialist palliative care is more than drugs: a retrospective study of ILD patients.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Corticosteroids in respiratory diseases in children

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1)

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Sildenafil improves walk distance in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

High-dose acetylcysteine in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

A study of the cough reflex in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

An alternative therapy for idiopathic pulmonary fibrosis by doxycycline through matrix metalloproteinase inhibition

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Dyspnea in idiopathic pulmonary fibrosis: a systematic review

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Dyspnea in interstitial lung disease

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Development and validity testing of an IPF-specific version of the St George's Respiratory Questionnaire

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Development of the ATAQ-IPF: a tool to assess quality of life in IPF

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Burden of illness in idiopathic pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202040

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38064381&oldid=2151954336"